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Pistacia lentiscus (Anacardiaceae) is commonly used in folk medicine to treat various dis-
eases. The aim of the present study was to evaluate the hepatoprotective and antioxidant
activities of extracts of P. lentiscus leaves (PL) and fruits (PF) against experimentally induced
liver damage. Furthermore, characterization of extracts was attempted by a spectroscopic
methodology (Fourier transform infrared spectroscopy) and high-performance liquid
chromatography with diode array detection analysis. A hepatoprotective potential against
paracetamol [165 mg/kg body weight (b.w.)] toxicity was noticed in mice pretreated with
the same dose of PL or PF extract (125 mg/kg b.w.) or a combination of both (PL/PF 63/63 mg/
kg b.w.), as revealed by an analysis of biochemical parameters (alanine aminotransferase,
aspartate aminotransferase, and alkaline phosphatase activities and total bilirubin). These
results were confirmed by histological examination of the liver, which revealed significant
protection against paracetamol-induced hepatic necrosis. Furthermore, PF extract exhibi-
ted a promising antidiabetic activity in streptozotocin-induced diabetic rats, similar to the
reference drug glibenclamide (0.91 g/L), a result confirmed by in vitro inhibition of a-
amylase. We demonstrated that the leaf crude extract showed the best effect in all tested
methods, compared to its fruit counterpart, probably due to the presence of higher
amounts of phenolic compounds, as determined by phytochemical and Fourier transform
infrared spectroscopy analyses. Moreover, high-performance liquid chromatography with
diode array detection led to the identification of six compounds for each part of the plant.
Gallic acid, a characteristic compound of Pistacia species, was most abundant in leaves and
fruits, while luteolin was detected for the first time in fruits. Obtained activities of P. len-
tiscus extracts may well be due, at least in part, to the presence of the above compounds.
Copyright © 2016, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).imie Appliquee, Faculte d
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The liver, a key organ of metabolism and excretion, is
continually exposed to a variety of xenobiotics and thera-
peutic agents. About 20,000 deaths are recorded every year
due to liver disorders, caused in some cases by paracetamol, a
well-known analgesic and antipyretic agent. Taken at high
doses, paracetamol is hepatotoxic since it generates the
highly reactive metabolite N-acetyl-p-benzoquinoneimine,
which induces glutathione depletion and oxidative stress,
leading to hepatic necrosis [1]. Antioxidant compounds of
natural origin, mostly polyphenols found in medicinal plants,
can counteract the harmful toxic side effects of modern drugs
by providing hepatoprotective capacity. Preserving the liver of
people suffering from diabetes is also important, since the
disease induces oxidative stress resulting from glucose
oxidation [2,3]. The number of diabetes cases is currently
about 117 million globally and predicted to reach 336 million
by the end of 2030 [4]. Indeed, a number of in vitro and in vivo
studies have shown that plant polyphenols can be used as
chemopreventive agents against different metabolic diseases
[5]. The current modern approach to treating diabetes,
including insulin and various oral antidiabetic synthetic
drugs, has demonstrated its limits, with unsatisfactory results
and many side effects [6]. The challenging issue for re-
searchers was to seek natural analogs of insulin and amylin,
in addition to alpha-glucosidase inhibitors, devoid of toxicity.
In that perspective, more than 1200 plants were identified
experimentally to be used in the treatment of diabetes, due to
the interesting biological properties of their constituent
polyphenols [7]. Indeed, according to the World Health Orga-
nization, approximately 80% of the inhabitants of this planet
have recourse to traditional medicines. As in many countries
of the world, this type of medicine is a part of the Algerian
culture, as it is resourced in a rich agricultural heritage of
rejuvenated herbs and food traditionally used for curing
several ailments, including diabetes [7]. Nevertheless, the use
of medicinal plants should be subjected to systematically
screening assays, accompanied by objective data analysis to
ascertain their safety, for the purpose of discovery and
development of new efficient drugs [8e10].
Pistacia lentiscus, a sclerophyll evergreen shrub and a
member of the Anacardiaceae family, largely distributed in
extreme ecosystems of the Mediterranean basin [11,12], is
widely used in phytotherapy for its sedative, antiatherogenic,
and antioxidant properties [13]. The aerial parts of P. lentiscus
are used in folk medicine as stimulants and diuretics, and to
treat hypertension, cough, sore throat, eczema, stomach ache,
and kidney stones and jaundice [14]. Fruits are consumed raw
or roasted, while their oil has versatile medicinal uses either
internally in the treatment of ulcers or externally to heal
psoriasis [14]. In addition to their therapeutic effects, P. len-
tiscus parts are also used in the food industry. For example,
essential oils obtained from aerial parts of P. lentiscus are used
as flavoring agents in alcoholic beverages and chewing gum
[15]. Moreover, the anthocyanins extracted from the fruits are
exploited as food colorants, and the oil rich in mono-
unsaturated and omega-3 fatty acids such as oleic acid and
linolenic acid, a high quantity of phytosterols such as b-sitosterol, and vitaminsmay potentially be included in animal
and human diets as antioxidants [16]. The protective effect of
P. lentiscus can be due to the presence of flavonoids, antho-
cyanins, hydrolysable tannins, and flavonoid glycosides
[11,17]. Hence, the present study focused on evaluating the
potential hepatoprotective effect of ethanolic extracts from P.
lentiscus leaves (PL) and fruits (PF) on paracetamol-induced
liver injury in mice and their antidiabetic effect on rats. To
contribute to the existing pool of local plants with claimed
antidiabetic activity, in vivo experiments on streptozotocin
(STZ)-induced diabetic rats were selected for anti-
hyperglycemic activity. Antioxidant properties of PL and PF
extracts were also investigated by evaluating oxygen uptake
inhibition during oxidation of methyl linoleate. Finally, the
subacute toxicity of the plant parts was assessed in vivo.2. Methods
2.1. Plant material
The leaves and fruits of P. lentiscuswere harvested in the forest
of Tizi Neftah in the suburbs of Amizour city by the Depart-
ment of Bejaia (Bejaia, Northeastern Algeria). The plant was
identified in the Laboratory of Botany (University of Bejaia)
where a specimen was deposited. The Laboratory of Botany
(University of Bejaia) does not have a specific voucher spec-
imen. In fact, only the characteristics of the plant as well as its
place and date of harvest and the person who identified the
plant are recorded. However, the same plant is recorded by
one of our colleagues in the Herbarium of Natural History,
Museum of Aix-en-Provence, France, under the voucher
specimen (D-DH-2013-37-5) [18]. After drying, leaves and fruits
of P. lentiscus were ground using an electric mill (Kika Labor-
technik, Stoufen, Germany), to give, respectively, a fine pow-
der (63 mm) and a paste.
2.2. Animals
Albino male mice (17e20 g) and Wistar rats (180e200 g) were
obtained from the Center of Research and Development (CRD-
SAIDAL, Algiers, Algeria). Animals were housed in cages and
maintained on a 12-hour light/dark cycle, at a temperature of
~23C, with constant humidity. They were allowed to accli-
matize to laboratory conditions for a week before starting the
experiment. Drinking water and food were provided ad libitum
throughout the experiment, except for a short fasting period
of 12 hours prior to treatment. Animals were handled ac-
cording to the recommendations of the International Ethics
Committee (Directive of the European Council 86/609/EC).
2.3. Extraction procedure
The extraction was conducted according to a well-established
procedure [19]. Leaf powder and fruit paste were macerated
separately in ethanol (1:4 w/v) for 24 hours with mechanical
agitation. After evaporation, the ethanol extract was frac-
tionated by solvent partition between ethyl acetate and water
(1:3:1 w/v/v) to obtain two distinct phases, organic and
aqueous phases, which were separately dried. The organic
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and water (1:3:1 w/v/v) to obtain another two fractions that
were separately dried. At the end, five different extracts for
each part of this plant were collected and tested for various
activities.
2.4. Determination of total phenols, flavonoids, and
tannins
Total phenols were determined by the FolineCiocalteu pro-
cedure [20]. Aliquots (0.1mL) of test solutionswere transferred
into test tubes and volumes were brought up to 0.5 mL by
FolineCiocalteu phenol reagent (1:10 v/v) and 1000 mL of
distilled water, followed by the addition of 1500 mL of sodium
carbonate solution (20%). After incubation for 2 hours in the
dark and at room temperature, the absorbance was measured
at 760 nm and the results were expressed as milligrams of
catechin equivalent per gram of dry weight of extract
(mg C Eq/g).
Quantification of flavonoids was performed using known
colorimetric methods [21] by the addition of aluminum chlo-
ride reagent (AlCl3) to the solution containing the extract. A
volume of 1 mL of extract (100 mg/mL) was combined with
500 mL of aluminum chloride solution (133 mg of
AlCl3 þ 400 mg of CH3CO2Na) dissolved in 100 mL of distilled
water. The absorbance was recorded at 430 nm, and concen-
trations of flavonoids were deduced from a standard curve
and expressed as milligrams of rutin equivalent per gram of
extract (mg R Eq/g).
Determination of tannin content in P. lentiscus extracts was
performed according to the method described by Hagerman
and Butler [22]. Two milliliters of a solution of bovine serum
albumin (1 mg/mL prepared in 200mM acetic acid and 170mM
NaCl adjusted to pH 4.9) were added to 1 mL (1 mg/mL) of
extract solution. The mixture was incubated for 24 hours at
4C for plant extract and for 15 minutes at room temperature
for tannic acid used as standard, and then centrifuged at 3000g
for 15 minutes. The pellet was dissolved in 4 mL of sodium
dodecyl sulfate (SDS)-triethanolamine solution [1% SDS and
5% triethanolamine (v/v) in distilled water]. One milliliter of
ferric chloride reagent (0.01M ferric chloride in 0.01N hydro-
chloric acid) was added and the solutions were mixed
immediately. After 30 minutes, the absorbance was recorded
at 510 nm and results were expressed as milligrams of tannic
acid equivalent per gram of extract (mg TA Eq/g).
2.5. Fourier transform infrared spectroscopy analysis
Fourier transform infrared (FTIR) spectrawere recorded as KBr
disks on a Perkin Elmer FTIR spectrometer SPECTRUM 2000
(Waltham, Mass, USA) in the wave number range between
4000/cm and 400/cm. Finely divided extract samples (9 mg)
were dispersed in amatrix of KBr (300mg) and pressed to formACE ¼ DPðO2Þ2:5hðin absence of extractÞ  DPðO2Þ2:5hðin presence of
DPðO2Þ2:5hðin absence of extractÞpellets. This method is used to deduce information on the
nature of the chemical bonds present in a compound. All
comparisons were made qualitatively, due to the difficulty in
defining a reference spectral band and to perform quantitative
measurements [23].2.6. High-performance liquid chromatography analysis
High-performance liquid chromatography (HPLC) analysis
was carried out using an Agilent 1200 Series LC system (Agi-
lent Technologies, Palo Alto, CA, USA) equipped with an on-
line vacuum degasser, a thermostated autosampler (15C), a
quaternary pump, and a diode array detector (DAD). The col-
umn used for chromatographic separation was a Kinetex PFP
(100  4.6 mm2, 2.6 mm; Phenomenex, Utrecht, The
Netherlands) thermostated at 30C.
The phenolic compounds were separated at a flow rate of
0.1 mL/min using the following gradient composed of water
with 0.1% formic acid (eluent A) and acetonitrile with 0.1%
formic acid (eluent B): 5% B at 0 minutes, 5% B at 6 minutes,
20% B at 13 minutes, 60% B at 17 minutes, 100% at 20 minutes;
and a final reconditioning cycle of 6 minutes at 5% B. The in-
jection volume was 5 mL. The compounds separated were
monitored with the DAD at 250 nm, 280 nm, 315 nm, and
370 nm, and peak spectra were acquired from 200 nm to
400 nm. All analyses were carried out in triplicate (n ¼ 3).
Constituent phenols were identified by comparing retention
times with known commercial pure standards purchased
from Sigma-Aldrich (St. Louis, MO, USA) (gallic acid, catechin,
syringic acid, ellagic acid, 3,4-dihydroxyhydro-cinnamic acid,
benzoic acid, salicylic acid, quercetin 3-O-rhamnoside, and
luteolin). Quantification was equally performed by external
standardization using solutions (5  103e1 mg/mL) of each
pure commercial compound.2.7. Evaluation of antioxidant activity
Antioxidant properties of PL and PF extracts were investigated
by evaluating oxygen uptake inhibition during oxidation of
methyl linoleate [24]. Oxidation was induced by molecular
oxygen in a gas-tight borosilicate glass apparatus (60C), using
butan-1-ol. Initial conditions inside the vessel were as follows:
methyl linoleate (99%; Fluka, Buchs, Switzerland), 0.4 mol/L;
2,20-azodiisobutyronitrile (98%; Fluka), 9  103 mol/L; plant
extract, 0.4 g/L; and oxygen pressure, 200 hPa. Oxygen uptake
was monitored continuously by a pressure transducer.
Without any additive, oxygen uptake is roughly linear and
constitutes the control. In the presence of an antioxidant,
oxygen consumption is slower, and the antioxidant capacity
of extract (ACE) was estimated by comparing oxygen uptake at
a chosen time (150 minutes), in the presence and absence of
extract, according to the following formula:extractÞ  100 (1)
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antioxidant.
2.8. Subacute toxicity study
Wistar albino rats, starved overnight, were divided into five
groups (n ¼ 5) and were given oral daily doses of P. lentiscus
ethanol leaf and fruit extracts [50 mg/kg body weight (b.w.)
and 250 mg/kg b.w.], except for the last group (control), which
received distilled water. Food was provided to the rats
approximately 1 hour after treatment. Observations for signs
of toxicity were conducted daily within the first 6 hours of the
treatment, which included weight measurements and visual
recordings of mortality, behavior, changes in physical
appearance, injury, pain, and signs of illness during the
28 days of treatment period.
At the end of the study, blood was collected from the retro-
orbital sinuses and centrifuged at 3500g for 15 minutes, and
sera were collected and used for the analysis of biochemical
parameters [glucose, aspartate aminotransferase (AST),
alanine aminotransferase (ALT), alkaline phosphatase (ALP),
total bilirubin, cholesterol, triglycerides, and creatinine]. An-
imals were sacrificed and quickly dissected, and their livers
and kidneys were removed and fixed in 10% formalin. The
organs were dehydrated in ascending grades of ethanol,
cleared in xylene, and embedded in paraffin. The hematox-
ylineeosin staining method was used before thorough ob-
servations under the microscope for histological analysis.
2.9. Hepatoprotective activity
The method described by Nithianantham et al [9] was
employed, with some minor modifications. Mice (18e20 g)
were divided into five groups (n ¼ 7). Negative and positive
control groups (GI and GII, respectively) orally received a dose
of 10 mL/kg b.w. of saline (0.9%) and paracetamol (165 mg/
kg b.w. per day), respectively. Animals of Groups III, IV, and V
(GIIIeGV) received orally 125 mg/kg b.w. of P. lentiscus leaf
ethanol extract (PL), 125mg/kg b.w. of fruit ethanol extract (PF)
extract, and leaf (63mg/kgb.w.)þ fruit (63mg/kgb.w.) extracts,
respectively, 3 hours after administration of paracetamol. The
treatments were sustained for 3 days, which were followed
24 hours later by sacrificing and dissecting all animals.
2.9.1. Assessment of hepatoprotective activity
After sacrifice, blood was collected and centrifuged at 3500g
for 15 minutes, and sera were separated and stored at 20C
until use for the analysis of biochemical parameters (AST,
ALT, and bilirubin).
2.9.2. Sample preparation of histological sections
For histological studies, livers of all animal groups were
removed, rinsed with cold saline (0.9%), and fixed in 10%
formalin solution.
Histopathological parameters for liver and kidney tissues
were scored as described by Eidi et al [25] and Arsad et al [26],
with a score of 0 showing no changes, and 1, 2, 3, and 4 indi-
cating mild, moderate, extensive, and severe changes,
respectively. The scores for histopathological parameters for
liver and kidney can be explained as follows: Score 0 ¼ novisible cell damage; Score 1 ¼ focal cells damage on < 30% of
the tissue; Score 2 ¼ focal cells damage on 30e50% of the tis-
sue; Score 3 ¼ extensive, but focalized cell lesions, more than
50%; and Score 4 ¼ global cells necrosis.
2.9.3. Lipid peroxidation inhibitory activity
Lipid peroxidation was assayed spectrophotometrically by
measuring malondialdehyde (MDA) levels [27]. Excised livers
from all groups were homogenized in ice-cold KCl (1.15%; 10%
w/v), and the resulting homogenate was centrifuged at 2500g
for 10 minutes to remove cellular debris. The supernatant
(0.5 mL) was added to 0.5 mL of Trichloroacetic acid (TCA)
(20%) and 1 mL of Thiobarbituric acid (TBA) (0.67%), and the
mixture was heated at 100C for 15 minutes, cooled, and
supplementedwith 4mL of n-butanol. After centrifugation for
15 minutes at 1500g, the optical density of the supernatant
was determined using a spectrophotometer at 532 nm and the
MDA levels were expressed as nmol MDA/mg of liver tissue,
calculated on the basis of the absorbance coefficient of the
TBAeMDA complex ( 3¼ 1.56  105/cm M).
2.10. Antidiabetic activity
2.10.1. In vivo antidiabetic activity
In this study, we investigated the possible antidiabetic effect
of the crude extract in STZ-induced diabetic rats. Animals
were fasted for 16 hours, after which they received a single
intraperitoneal injection of STZ (60 mg/kg b.w.) [28], freshly
prepared in 0.9% cold saline. Three days later, fasting blood
glucose was determined and the rats that developed diabetes
with glucose levels above 200 mg/dL were selected for the
study [29]. Animals were divided into six groups (n ¼ 5): Group
I (GI, diabetic control rats) received saline 0.9%; Group II (GII)
received glibenclamide (50 mg/kg b.w.), a known antidiabetic
drug; Groups III (GIII) and IV (GIV) received PL ethanol extract
(50mg/kg b.w. and 125mg/kg b.w., respectively); and Groups V
(GV) and VI (GVI, diabetic rats) received PF ethanol extract
(50 mg/kg b.w. and 125 mg/kg b.w., respectively). Extracts and
glibenclamide were given orally and blood was collected twice
(1 hour and 2 hours after treatment) through retro-orbital
sinus of rat eyes. Serum was separated by centrifugation at
2500g for 10 minutes, and blood glucose was estimated by the
glucose oxidase kit (cat. no-1001191; Spinreact, St Esteve de
Bas, Girona, Spain).
2.10.2. In vitro antidiabetic activity: a-amylase inhibitory
assay
The assay was carried out following the standard protocol
with slight modifications [30]. Starch azure (2 mg) was sus-
pended in 0.2 mL of 0.5M TriseHCl buffer (pH 6.9) containing
0.01M CaCl2 (substrate solution). The tubes containing sub-
strate solution were boiled for 5 minutes and then pre-
incubated at 37C for 5 minutes. Ethanol extracts of P. lentiscus
leaves and fruits were dissolved in dimethyl sulfoxide in order
to obtain concentrations of 20 mg/mL, 60 mg/mL, and 100 mg/
mL. Then, 0.2 mL of plant extract was added to the tube con-
taining the substrate solution, followed by the addition of
0.1 mL of Aspergillus oryzae a-amylase (4 units/mL; Sigma-
Aldrich) prepared in TriseHCl buffer (2 units/mL). The
mixture was incubated at 37C for 10 minutes, after which
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action. The solution was centrifuged at 1500g for 5 minutes at
4C, and the absorbance of the resulting supernatant was
measured at 595 nm. Acarbose, a known a-amylase inhibitor,
was used as a standard drug. The a-amylase inhibitory activity
(AIA) was calculated using the following formula:
AIA ¼ [(Acþ e Ace) e (As e Ab)]/(Acþ e Ace)  100, (2)
whereAcþ,Ace,As, andAb are defined as the absorbencies of
100% enzyme activity (only solvent with enzyme), 0% enzyme
activity (only solvent without enzyme), test sample (with
enzyme), and blank (test sample without enzyme), respec-
tively. The concentration of acarbose and plant extracts
required to inhibit 50% of a-amylase activity was defined as
the IC50 value.2.11. Statistical analysis
In vitro results were obtained from three independent exper-
iments and were expressed as mean ± standard deviation.
The one-way analysis of variance (ANOVA) was performed
using GraphPad Prism followed by NewmaneKeuls multiple
comparison test. In vivo results were presented as
mean ± standard error of the mean. The analysis of variance
was performed using GraphPad Prism followed by Dunnett
test. The results are considered statistically significant at
p < 0.05, p < 0.01, and p < 0.001.3. Results and discussion
3.1. Determination of total phenols, flavonoids, and
tannins
Solvent extraction is frequently used for isolation of antioxi-
dants in plants taking into account the fact that the extraction
yield is dependent on the solvent and method of extraction,
and that different polarity may influence the different anti-
oxidant potentials of the constituent compounds. It wasTable 1 e Determination of total phenols, flavonoids, and tann
Extracts Total phenols
(mg C Eq/g extract) (
Leaves Fruits Lea
Ethanol 517.512 ± 5.53 254.9 ± 5.04b 108.67 ±
Ethyl acetate
Organic fraction 399.423 ± 9.33*** 100.7 ± 1.06b,*** 115.14 ±
Aqueous fraction 587.292 ± 28.8*** 281.84 ± 8.29b,*** 36.91 ±
Chloroform
Organic fraction 247.786 ± 2.79*** 69.32 ± 3.67c,*** 15.00 ±
Aqueous fraction 1104.603 ± 6.7*** 366.04 ± 10.54c,*** 253.82 ±
Data are presented as mean ± SD, n ¼ 3; one-way ANOVA followed by New
are significantly different.
* p < 0.05, ** p < 0.01, *** p < 0.001 compare all pairs of columns of differe
a p < 0.05, b p < 0.01, c p < 0.001 compare all pairs of columns of fruits ver
ANOVA ¼ analysis of variance; C Eq/g extract ¼ catechin equivalent per g
SD ¼ standard deviation; TA Eq/g extract ¼ mg tannic acid equivalent peestablished that higher extraction yields of phenolic com-
pounds were obtained with an increase in the polarity of the
solvent [31], in accordance with our findings. In fact, the
highest amounts of polyphenols were recorded in the aqueous
chloroform extracts of both leaves and fruits, followed by in
ethanolic and aqueous ethyl acetate extracts (Table 1). Our
results also showed that P. lentiscus is rich in tannins and not
in flavonoids, as reported previously [19] for the same plant.
Conversely, total amounts of phenolics and flavonoids of
leaf crude extracts (517.512 ± 5.53 mg C Eq/g and
108.67 ± 0.5 mg R Eq/g, respectively) were significantly
(p < 0.01) higher than those found in fruit crude extracts
(254.9 ± 5.04mg C Eq/g and 3.49 ± 1.19mg R Eq/g, respectively).
Quantification of total polyphenols (35 mg TA Eq/g of extract)
in a related species, Pistacia vera [31], showed the highest
levels in aqueous extracts, in agreement with our results and
with those of previous investigators who reported that 75% of
phenolic compounds of P. lentiscus are hydrolysable tannins
(galloylated tannins) [32], mostly soluble in aqueous solvents.
However, it has also been stated that any discrepancies in
phenolic concentrations may be due to the collection period
as well as soil conditions [33].3.2. FTIR analysis
The FTIR spectra of a potassium bromide (KBr) pellet of crude
extracts of P. lentiscus (leaves and fruits) are shown in Figure 1.
The spectra (Figure 1) show the presence of two bands of
strong intensity at 2853/cm and 2924/cm, characteristic of
CeH bonds of aliphatic CH2 and CH3 groups, respectively.
Moreover, characteristic carbonyl group (C]O) bands around
1700/cm (1701/cm, 1711/cm, and 1745/cm) are indicative of the
presence of phenolic acids. In fact, the low-value bands are
probably due to the presence of conjugated double bonds or
aromatic moieties in the vicinity of carboxylic acids. At
around 1600/cm, we found more aromatic cycles for both leaf
and fruit extracts. Vibrations of deformation of aliphatic
groupings CH2 and CH3 are found at 1377/cm and 1414/cm.
The absorption bands of the CeH bonds of an aromatic ring or
a double bond are around 3005/cm. Finally, the CeN functionins in extracts of Pistacia lentiscus leaves and fruits.
Flavonoids
mg R Eq/g extract)
Tannins
(mg TA Eq/g extract)
ves Fruits Leaves Fruits
0.5 3.49 ± 1.19c 409.87 ± 6.9 309.45 ± 6.88
1.52*** 7.41 ± 1.27c,* 171.47 ± 13.03*** 116.30 ± 14.08***
0.39*** 6.71 ± 2.16c,* 383.07 ± 5.17* 65.45 ± 3.01c,***
1.00*** 6.11 ± 0.46a,* 115.65 ± 10.05*** 69.68 ± 6.08c,***
0.46*** 16.57 ± 1.11c,*** 479.35 ± 22.22*** 226.95 ± 0.89b,***
maneKeuls test. Values in the same column sharing different letters
nt solvents versus ethanol.
sus leaves.
ram of extract; R Eq/g extract ¼ rutin equivalent per gram of extract;
r gram of extract.
AB
cm
–1
cm
–1
%
 T
%
 T
Figure 1 e FTIR spectra of the crude extracts of (A) Pistacia lentiscus leaves and (B) fruits. FTIR ¼ Fourier transform infrared
spectroscopy.
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cm and 1033/cm, featuring an aminophenol. Between 690/cm
and 900/cm, we detected a grouping OH- bond, most probably
due to the presence of an aromatic cycle. The detection of
these characteristic absorption bands confirms the richness of
fruit and especially leaf extracts in phenolic compounds.3.3. Identification and quantification of individual
phenolics
The phenolic profiles of PL and PF extracts obtained by
comparing retention times and UV spectra at 280 nm (Table 2)
with those of respective known standards (Table S1 and Figure
Table 2 e Quantitative and qualitative analyses of phenolics in PL and PF ethanolic extracts by HPLC-DAD.
Identified compounds Calibration curve R2 lmax (nm) r.t. (min) PL
(mg/g d.w.)
PF
(mg/g d.w)
Gallic acid y ¼ 14,538x 0.9986 280 1.64 161.67 ± 35.27 5.67 ± 0.017***
Catechin y ¼ 12,453x 0.9869 280 9.059 31.79 ± 5.76 0.2 ± 0.001***
Syringic acid y ¼ 66,229x 0.9914 280 10.149 52.66 ± 7.23 ND
Ellagic acid y ¼ 160,888x 0.9986 250 13.636 9.54 ± 0.63 ND
3,4-Dihydroxyhydro-cinnamic acid y ¼ 16,515x 0.9839 280 5.895 ND 0.07 ± 0.001
Benzoic acid y ¼ 8505.7x 0.9963 250 11.417 ND 0.6 ± 0.0
Salicylic acid y ¼ 23,187x 0.9972 315 13.29 ND 0.22 ± 0.007
Quercetin 3-O-rhamnoside y ¼ 75,791x 0.9991 370 16.020 0.12 ± 0.053 ND
Luteolin y ¼ 19,014x 0.9984 250 16.074 0.61 ± 0.01 2.97 ± 0.1***
Data are presented as means ± SD (n ¼ 3), one-way ANOVA, followed by NewmaneKeuls test.
* p < 0.05 comparing all pairs of columns.
** p < 0.01 comparing all pairs of columns.
*** p < 0.001 comparing all pairs of columns.
ANOVA ¼ analysis of variance; d.w. ¼ dry extract; HPLC-DAD ¼ high-performance liquid chromatography with photodiode array detection;
ND ¼ not detected; PF ¼ P. lentiscus fruits; PL ¼ P. lentiscus leaves; r.t. ¼ retention time; SD ¼ standard deviation.
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each part of the plant: gallic acid, catechin, syringic acid,
ellagic acid, quercetin-3-O-rhamnoside, and luteolin in leaves,
and gallic acid, catechin, 3,4-dihydroxyhydro-cinnamic acid,
benzoic acid, salicylic acid, and luteolin in fruits. The presence
of gallic acid and quercetin-3-O-rhamnoside in the leaves of P.
lentiscus was previously reported [34]. Gallic acid, identified in
both leaves and fruits, constitutes the basic unit of galloyl
tannins and is a hallmark of Pistacia species.
Quantification of the identified compounds, detected in the
leaves and fruits, was accomplished by external standardi-
zation. For this purpose, nine standard calibration curves
were established using the following commercial standards:
gallic acid, catechin, syringic acid, ellagic acid, 3,4-
dihydroxyhydro-cinnamic acid, benzoic acid, salicylic acid,
quercetin 3-O-rhamnoside, and luteolin, within the concen-
trations tested (5  10e31 mg/mL). The amount of each
identified phenolic compound [expressed as mg/g of dry
weight (d.w.)] is reported in Table 2. The data revealed both in
terms of qualitative and quantitative profiles, a significant
difference between Pistacia leaf and fruit extracts.
In fact, in PL, gallic acid (161.67 ± 35.27 mg/g) was found to
be the most abundant compound, followed by syringic acid
(52.66 ± 7.23 mg/g), catechin (31.79 ± 5.76 mg/g), and finally
ellagic acid (9.54 ± 0.63 mg/g). The presence of the latter
compound in PL is unprecedented. By contrast, fruits were a
poor source of phenolics, with gallic acid (5.67 ± 0.017 mg/g)
and luteolin (2.97 ± 0.1 mg/g) being the most abundant com-
pounds. However, it is important to mention that the present
study is the first to identify luteolin in P. lentiscus fruits.
High concentrations of compounds such as gallic acid and
catechin, which have shown important biological activities
[35], make the plant worthy of further research, offering
important therapeutic potentials against diabetes, as an anti-
inflammatory agent, or in alleviating aspects of the aging
process [34]. Among the molecules identified in P. lentiscus,
quercetin and catechin, isolated from Rhododendron groenlan-
dicum were proved to be active against diabetes [36]. The
identified phenolic compounds are known to be potent anti-
oxidant agents, which confers them strong biological prop-
erties including antidiabetic [3].Moreover, identification of the plant's active compounds
paves the way to their use for pharmacokinetic studies and in
the development of new therapeutic agents for the treatment
of metabolic diseases.
3.4. Antioxidant activity
The antioxidant properties of P. lentiscus were determined by
the oxygen consumption method. The oxygen uptake profile
during auto-oxidation ofmethyl linoleate is shown in Figures 2
and 3, for PL and PF extracts, respectively. Only two extracts
(ethanol andaqueouschloroform leaf extracts) reducedtherate
of oxygen consumption by 15% and 11%, respectively, less than
that of catechin (76%), but in agreement with previous results
[24,37]. The highest amounts of total phenols for ethanol and
chloroform aqueous extracts (517.51 ± 5.53 mg C Eq/g extract
and 1104.6 ± 6.7 mg C Eq/g extract, respectively) could be
responsible for the antioxidant properties of the extracts.
Polyphenols were demonstrated to have an important role in
stabilizing lipid peroxidation [38,39] and are associated with a
wide range of biological activities including antioxidant activ-
ity, due to their redox properties, as reducing agents or
hydrogen atom donors. It has already been reported that chlo-
roform aqueous fraction of PL extract strongly inhibited (99% at
100 mg/mL; IC50 ¼ 0.84 mg/mL) linoleic acid peroxidation [19]. In
corroborationwithourfindings, the leavesofP. lentiscus contain
antioxidant flavonol glycosides such as quercetin-3-O-
rhamnoside [40] that contribute to the high antioxidant po-
tential established in vitro [41] and in vivo [42].
3.5. Subacute toxicity study
General behavior and body weight are among the critical pa-
rameters for the evaluation of the first signs of toxicity [43].
Results did not reveal any significant changes in body weight
in the treated rats, compared with the control rats (Figure 4).
Both control and treated groups appeared healthy throughout
the period of study, although those receiving a high dose
(250 mg/kg b.w.) of either PL or PF extract exhibited minor
diarrhea, probably due to the laxative effect of the plant [44] or
due to its high content of tannins, which, by forming
Figure 2 e Oxygen uptake during the autoxidation of methyl linoleate induced by AIBN in the presence of different Pistacia
lentiscus leaf extracts and the reference (catechin). AIBN ¼ 2,2′-azodiisobutyronitrile.
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However, no death was recorded in all experimental groups,
suggesting that the LD50 (lethal dose, 50%) for chronic oral
dosing with P. lentiscus was much higher than 250 mg/kg b.w.
Biochemical parameters (cholesterol, glucose, and bili-
rubin) showed no significant changes in the treated rats
compared with the control rats (Table 3), suggesting that P.
lentiscus extracts had no effect on lipid and carbohydrate
metabolisms of the rats. However, a considerable increase
(p < 0.001) in triglyceride levels was noticed at high concen-
trations of PL and PF extracts (250 mg/kg b.w.), which may be
related to the presence of a high level of glycosylated flavo-
noids in these extracts [40]. Moreover, high concentrations of
PL extract caused a slight increase in ALT and a significant
(p < 0.001) increase in AST and ALP levels. By contrast, a sig-
nificant (p < 0.001) decrease in creatinine production in both
groups treated with leaf and fruit extracts at 250 mg/kg b.w.
was observed (Table 3), probably correlated to a reduction inFigure 3 e Oxygen uptake during the autoxidation of methyl lin
lentiscus fruit extracts and the reference (catechin). AIBN ¼ 2,2′musclemass due to weight loss, but indicating no impairment
in kidney function.
3.5.1. Histopathological examination
Histological sections supplemented by the histological
injury score (Table 4) have led to the following observations.
Histopathological studies of kidneys and livers of rats
exposed to subchronic treatment with PL and PF extracts
(50 mg/kg b.w. and 250 mg/kg b.w., respectively) did not
show any major aberrations in their structural integrity.
The liver is the main target organ of toxicity, which is
exposed to foreign substances absorbed in intestines and
metabolized to other compounds that may or may not be
hepatotoxic to the rats [46]. In this study, photomicrographs
of rat livers subchronically exposed to PL and PF extracts
(50 mg/kg) showed subnormal structure surrounded by
inflated hepatocytes and degeneration in hepatic plates
(Figures 5B and 5D).oleate induced by AIBN in the presence of different Pistacia
-azodiisobutyronitrile.
Figure 4 e Rat weight versus time. All values are expressed
as mean ± SEM, n¼ 5.Group A is the normal control group;
Group B, 50 mg/kg b.w. Pistacia lentiscus leaf crude extract-
treated group; Group C, 250 mg/kg b.w. P. lentiscus leaf
crude extract-treated group; Group D, 50 mg/kg b.w. P.
lentiscus fruit crude extract-treated group; and Group E,
250 mg/kg b.w. P. lentiscus fruit crude extract-treated
group. b.w. ¼ body weight; SEM ¼ standard error of the
mean.
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erated hepatocytes in liver sections of rats treated with leaf
extracts (Figure 5C), while higher steatosis with slight in-
flammatory infiltrations and minor focal necrosis were
noticeable in livers of rats treated with fruit extracts
(Figure 5E), compared with the controls (Figure 5A). These
results correspond closely to the above findings concerning
biochemical parameters of ALP and AST, which did not indi-
cate any toxicity at low levels (50 mg/kg b.w.) of PL and PF
extracts. However, at high levels (250 mg/kg b.w.), a slight
toxicity was noticed, which was more visible for fruit extracts
than for its leaf counterparts.
Photomicrographs of kidney sections of rats treated with
50 mg/kg b.w. of leaf extracts (Figure 6B) showed only minorTable 3 e Blood parameter levels of different rat groups treated
fruits.a
Parameters Group A Group B
(50 mg/kg b.w.) (25
Glucose (g/L) 1.066 ± 0.05 1.298 ± 0.12 1
ALT (IU/L) 29.8 ± 1.16 30.6 ± 5.03
AST (IU/L) 85.4 ± 6.14 71.4 ± 6.15 13
ALP (IU/L) 218 ± 13.27 227.6 ± 22.41 3
TB (mg/L) 1.1 ± 0.04 1.02 ± 0.05
CHOL (g/L) 0.47 ± 0.03 0.442 ± 0.05 0
TRG (g/L) 0.442 ± 0.04 0.488 ± 0.07 1
CREA (mg/L) 9 ± 0.30 9.8 ± 0.83 0
Data are presented as means ± SEM, n ¼ 5. One-way ANOVA followed by
* p < 0.05 versus control group.
** p < 0.01 versus control group.
*** p < 0.001 versus control group.
ALP ¼ alkaline phosphatase; ALT ¼ alanine aminotransferase; ANOVA ¼
weight; CHOL ¼ cholesterol; CREA ¼ creatinine; SEM ¼ standard error of
a Animal groups are as follows: Group A, control group; Group B, 50mg/kg
kg b.w. P. lentiscus leaf ethanolic extract-treated group; Group D, 50 mg/
250 mg/kg b.w. P. lentiscus fruit ethanolic extract-treated group.necrosis of tubular epithelial cells; dilated hypocellular tu-
bules with cells were found in the tubular lumen, whereas the
kidneys of the fruit extract-treated group seemed completely
normal (Figure 6D), compared with the control group
(Figure 6A). At 250mg/kg b.w., a distension of the renal tubules
was observed in the case of the leaf extract-treated group
(Figure 6C) and a slight necrosis for the fruit extract-treated
group (Figure 6E), compared with the control group
(Figure 6A). We conclude that histological examination of the
organs of rats treated with P. lentiscus extracts at a dose of
50 mg/kg b.w. revealed that there was no major potential
toxicity or damage to the cell structure of livers and kidneys.3.6. Hepatoprotective activity
3.6.1. Biochemical parameters
The effects of P. lentiscus extracts on livermarker enzymes and
serum bilirubin content presented in Table 5 showed that
intoxication with paracetamol (165 mg/kg/d) for 3 days
generated liver damage reflected by a significant increase in
AST, ALT, ALP, and bilirubin levels, compared with the normal
control group. The elevated level of bilirubin is usually an
indication of biliary obstruction, hemolysis, and in some cases
renal failure [47,48]. However, administration of PL or PF
extract, or a mixture (PL/PF) of both, attenuated serum
enzyme levels and caused a subsequent recovery toward
normalization, with more efficiency for PL extract. This result
is indicative of a better hepatoprotective potential of leaves
compared to that of fruits and was also seen in the group that
received a combined treatment of leaves and fruits (75.54 IU/L,
214.14 IU/L, and 137.54 IU/L for ALT, AST, and ALP, respec-
tively) and total bilirubin (0.54 mg/L).
3.6.2. Lipid peroxidation inhibitory activity
Paracetamol-treated mice showed a significant (p < 0.001) in-
crease in serum lipid peroxidation asmeasured by the amount
of MDA formed (0.4 ± 0.098 nmol/mg liver tissue), comparedwith ethanolic extracts of Pistacia lentiscus leaves and
Group C
0 mg/kg b.w.)
Group D
(50 mg/kg b.w.)
Group E
(250 mg/kg b.w.)
.380 ± 0.08 1.293 ± 0.07 1.502 ± 0.13*
35.1 ± 1.30 31.12 ± 2.77 33.8 ± 3.64
5.02 ± 3.51*** 66.48 ± 3.59 91.2 ± 2.32*
71.8 ± 23.13** 222.2 ± 39.4 389.6 ± 28.91***
0.7 ± 0.08 0.752 ± 0.22 0.648 ± 0.01*
.344 ± 0.01* 0.532 ± 0.04 0.486 ± 0.01
.465 ± 0.15*** 0.4866 ± 0.05 1.38 ± 0.19***
.388 ± 0.01*** 4.16 ± 0.16*** 0.41 ± 0.01***
Dunnett t test.
analysis of variance; AST ¼ aspartate aminotransferase; b.w. ¼ body
the mean; TB ¼ total bilirubin; TRG ¼ triglyceride.
b.w. P. lentiscus leaf ethanolic extract-treated group; Group C, 250mg/
kg b.w. P. lentiscus fruits ethanolic extract-treated group; and Group E,
Table 4 eHistological injury score of liver and kidney after treatment for 28 dayswith ethanolic extracts of Pistacia lentiscus
leaves and fruits.a
Groups Injury scoreb
Liver Kidney
Necrosis Infiltration of
inflammatory
cells
Fatty
degeneration
Degenerated
hepatocyte
Sinusoidal
dilatation
Dilated
hypocellular
tubules
Intratubular
debris
Coagulate
necrosis of
tubular
epithelial cells
Group A
(control)
0 0 0 0 0 0 0 0
Group B
(50 mg/kg b.w.)
0 0 0 3 0 1 1 2
Group C
(250 mg/kg b.w.)
0 0 3 1 2 4 0 0
Group D
(50 mg/kg b.w.)
0 0 3 0 2 1 0 1
Group E
(250 mg/kg b.w.)
1 2 4 1 2 2 0 3
b.w. ¼ body weight.
a Animal groups are as follows: Group A, control group; Group B, 50mg/kg b.w. P. lentiscus leaf ethanolic extract-treated group; Group C, 250mg/
kg b.w. P. lentiscus leaf ethanolic extract-treated group; Group D, 50 mg/kg b.w. P. lentiscus fruit ethanolic extract-treated group; and Group E,
250 mg/kg b.w. P. lentiscus fruit ethanolic extract-treated group.
b Livers and kidneys were scored for histological injury via lightmicroscopywith Score 0¼ no visible cell damage; Score 1¼ damage <30% of the
tissue; Score 2 ¼ damage on 30e50% of the tissue; Score 3 ¼ extensive, lesions >50%; and Score 4 ¼ complete necrosis.
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contrast, extract-treated groups exhibited a significant and
comparable decrease in MDA levels (0.33 ± 0.046 nmol/mg and
0.31 ± 0.042 nmol/mg liver tissue, for leaves and fruits,
respectively), the decrease being more pronounced after the
combined treatment of both parts of the plant
(0.26 ± 0.031 nmol/mg liver tissue; Figure 7). The latter data are
suggestive of a synergistic action between the constituents of
leaf and fruit extracts. It also consolidates the above findings
concerning the better efficiency of the combined treatment in
reducing serum marker enzymes and those of previous find-
ings that reported that Pistacia atlantica extract showed good
antilipoperoxidation potential and protected red blood cells
against CCl4-induced damage [49]. Furthermore, an earlier
study demonstrated the hepatoprotective effect of extracts
derived from boiled and nonboiled P. lentiscus leaf homoge-
nates against CCl4 cytotoxicity by reducing the activity of ALP,
ALT, and AST, as well as bilirubin level [50]. In agreement with
previous studies that demonstrated that flavonoids increase
the intracellular glutathione concentrations [51], it is probable
that the richness of P. lentiscus extracts in various important
flavonoids such as catechin and quercetin glycoside prevents
the exhaustion of glutathione by N-acetyl-p-benzoquinonei-
mine, thereby enhancing the hepatoprotective potential of
leaf extract.
3.6.3. Histopathological analysis
The present study underlines the potential hepatoprotective
activity of P. lentiscus against hepatic injury caused by para-
cetamol in mice (Table 6). Paracetamol is a well-known anti-
pyretic and analgesic agent, safe in therapeutic doses, but can
produce fatal hepatic necrosis in humans, rats, and mice at
high doses [52]. Histopathological studies (Figure 8) revealed
major damage in the liver of animals intoxicated withparacetamol (GII), compared with the normal control group
(GI). This toxicitymay be due to depletion of glutathione stores
or free radical generation initiating lipid peroxidation [1], the
latter being revealed by the higher MDA levels found above
(0.4 ± 0.098 nmol/mg liver tissue). Liver biopsy (Figure 8)
revealed cell necrosis, deeply stained nuclei, sinusoidal dila-
tation, and degeneration of hepatocytes with lymphocyte
infiltration in the sections of livers of mice injected with
paracetamol at a dose of 165 mg/kg (Figure 8, GII). In the leaf
extract-treated group (Figure 8, GIII), the liver architecturewas
similar to that observed in the control group (Figure 8, GI),
except for slight necrosis (score¼ 4) (score¼ 2) that occupies a
small area (Figure 8, GIII). In the fruit extract-treated group,
the necrosis is very pronounced and localized around the
congested central vein (Figure 8, GIV). However, administra-
tion of both leaf and fruit extracts prevented liver injury
(Figure 8, GV), probably by reducing lipid peroxidation
(0.26 ± 0.031 nmol/mg liver tissue). This effect indicates a
synergistic activity of compounds present in fruits and leaves.
Our findings are in strong agreement with those of a study on
a related species, P. atlantica, which reported that the extract
obtained from this plant stopped lipid peroxidation and pro-
tected red blood cells against CCl4-induced damage [49].
3.7. Antidiabetic activity
3.7.1. In vivo antidiabetic activity
STZ is well known for its selective pancreatic b-cell cytotox-
icity and has been extensively used to induce diabetes melli-
tus in animals [53]. Induction of diabetes in rats was
confirmed by the presence of a high fasting plasma glucose
level in the control animals injected with STZ, as depicted in
Figure 9. The reduction in blood glucose levels in both PL and
PF extract-treated rats was observed 1 hour after treatment,
Figure 5 e Effect of PL and PF crude extracts on rat livers after treatment for 28 days. Histological changes in rat liver after
treatment with Pistacia lentiscus leaf and fruit crude extracts are shown. Rats were administered orally 50 mg/kg b.w. and
250 mg/kg b.w. of leaf and fruit crude extracts. The liver was stained with hematoxylin and eosin method: (A) control group
(normal central vein and hepatocytes); (B) 50 mg/kg b.w. PL-treated group (light steatosis); (C) 250 mg/kg b.w. PL-treated
group (steatosis); (D) 50 mg/kg b.w. PF-treated group (sub-normal structure); and (E) 250 mg/kg b.w. PF-treated group (light
necrosis) (magnification 200£). Each arrow indicates an adipocyte linked to a lateral nucleus membrane. cv ¼ central vein;
d ¼ degenerated hepatocytes; h ¼ surrounding hepatocytes; m ¼ infiltration of inflammatory cells; n ¼ focal necrosis;
PF ¼ P. lentiscus fruits; PL ¼ P. lentiscus leaves; s ¼ dilated hepatic sinusoids.
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hours of treatment with PL extracts, blood glucose level was
restored to normal values (0.91 ± 0.16 g/L), for both concen-
trations used (50 mg/kg b.w. and 125 mg/kg b.w.), as good as
the reference drug glibenclamide (0.91 ± 0.13 g/L). Conversely,
blood glucose level decreased but remained relatively high
(1.45 ± 0.07 g/L) after treatment with fruits extracts.
Recent studies indicated that P. lentiscus leaf extracts
contain several phytochemical constituents such as rutin,quercetin, isoquercetin, and myricetin [54,55], which enhance
insulin release and glycogen metabolism, and decrease blood
glucose levels in diabetic animals [56], while others argue in
favor of inhibition of nuclear factor-kB activation and resto-
ration of enzymatic antioxidants [57]. We have documented
the presence of considerable amounts of gallic acid, catechin,
and ellagic acid in PL extracts, which, as phytoconstituents of
Terminalia paniculata bark, have been demonstrated to act in
the management of glucose in diabetic rats [58]. In parallel,
Figure 6 e Effect of PL and PF crude extracts on rat kidneys after treatment for 28 days. Histological changes in kidneys of
rats treated with Pistacia lentiscus leaf and fruit crude extracts are shown. Rats were administered orally 50 mg/kg b.w. and
250 mg/kg b.w. of plant extracts. Kidney tissue was stained with hematoxylin and eosin: (A) control rats group (normal
kidney structure); (B) 50 mg/kg b.w. PL-treated group (minor necrosis); (C) 250 mg/kg b.w. PL-treated group (distension of the
renal tubules); (D) 50 mg/kg b.w. PF-treated group (subnormal kidney structure); and (E) 250 mg/kg b.w. PF-treated group
(light necrosis) (magnification 250£). Arrows indicate coagulate necrosis of tubular epithelial cells and arrow heads dilated
hypocellular tubules. D ¼ intratubular debris; G ¼ glomeruli; PF ¼ P. lentiscus fruits; PL ¼ P. lentiscus leaves.
Table 5 e Effect of ethanolic extracts of Pistacia lentiscus leaves and fruits on liver marker enzymes and serum bilirubin.a
Groups GI GII GIII
(125 mg/kg b.w.)
GIV
(125 mg/kg b.w.)
GV
(63/63 mg/kg b.w.)
ALT (IU/L) 34.5 ± 1.3c 90.67 ± 6.5*** 86.34 ± 4.87*** 69.57 ± 4.05** 75.54 ± 13.79**
AST (IU/L) 78.9 ± 1.78c 241.83 ± 28.7*** 190.4 ± 27.04** 225.21 ± 22.85*** 214.14 ± 24.29***
ALP (IU/L) 77.9 ± 9.85c 210.5 ± 4.7*** 125.26 ± 14.27*,c 148.43 ± 17.37**,b 137.54 ± 11.28**,c
TB (mg/L) 0.46 ± 0.19c 2.42 ± 0.17*** 1.23 ± 0.22*,c 1.5 ± 0.28 **,a 0.54 ± 0.11 **,c
Results are expressed as mean ± SEM, n ¼ 7; one-way ANOVA followed by Dunnett t test.
* p < 0.05, ** p < 0.01, *** p < 0.001 compare all animals treated groups versus normal control.
a p < 0.05, b p < 0.01, c p < 0.001 compare all animals treated groups versus paracetamol treated.
ALP ¼ alkaline phosphatase; ALT ¼ alanine aminotransferase; ANOVA ¼ analysis of variance; AST ¼ aspartate aminotransferase; b.w. ¼ body
weight; SEM ¼ standard error of the mean; TB ¼ total bilirubin.
a The animal's groups are as follows: GI, normal control; GII, 165 mg/kg b.w. paracetamol-treated group; GIII, 125 mg/kg b.w. P. lentiscus leaf
ethanolic extract-treated group; GIV, 125mg/kg b.w. P. lentiscus fruit ethanolic extract-treated group; and GV, 63/63mg/kg b.w. P. lentiscus leaf/
fruit ethanolic extract-treated group.
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Figure 7 e MDA levels in different treated groups. All
values are expressed as mean ± SEM, n ¼ 7. One-way
ANOVA followed by Dunnett multiple comparison test was
used for statistical significance. The animal groups are as
follows: GI, normal control group; GII, 165 mg/ kg b.w.
paracetamol-treated group; GIII, 125 mg/kg b.w. Pistacia
lentiscus leaves crude extract-treated group; GIV, 125 mg/
kg b.w. P. lentiscus fruits crude extract-treated group; and
GV, 63/63 mg/kg b.w. P. lentiscus leaves/fruits crude
extract-treated group. * p < 0.05, when compared with
normal control values. ** p < 0.01, when compared with
normal control values. *** p < 0.001, when compared with
normal control values. ANOVA ¼ analysis of variance;
b.w. ¼ body weight; MDA ¼ malondialdehyde;
SEM ¼ standard error of the mean.
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acid found in Eugena uniflora leaves could contribute to
increasing serum insulin levels in diabetic mice [59]. These
same authors have linked the observed activity to the anti-
oxidant potential of plant extracts. In a similar study, it has
been indicated that the antioxidative effect of CleistocalyxTable 6 e Histological injury score of liver after paracetamol tre
leaves and fruits.a
Groups
Injury of s
Necrosis Infiltration of
inflammatory cells
GI 0 0
GII 4 3
GIII
(125 mg/kg b.w.)
2 0
GIV
(125 mg/kg b.w.)
2 0
GV
(63/63 mg/kg b.w.)
1 0
b.w. ¼ body weight.
a The animal's groups are as follows: GI, normal control; GII, 165 mg/ kg
ethanolic extract-treated group; GIV, 125mg/kg b.w. P. lentiscus fruit etha
fruit ethanolic extract-treated group.
b Livers were scored for hepatic injury via lightmicroscopywith Score 0¼
the tissue; Score 2 ¼ focal hepatocyte damage on 30e50% of the tissue
4 ¼ global hepatocyte necrosis.operculatus flower buds might be responsible for the reduction
in the oxidative cytotoxic status of b-cells, leading to their
protection and prevention of insulin deficiency [60]. Thus, the
significant antidiabetic effect of P. lentiscus ethanolic extract
could be attributed to the presence of various phytocon-
stituents with antioxidant properties detected in the phyto-
chemical screening, FTIR analysis, and HPLC-DAD, acting
individually or in synergy. The higher contents of total poly-
phenols and flavonoids in leaves over their fruit counterpart
(Tables 1 and 2) could account for the higher hypoglycemic
activity.
3.7.2. In vitro antidiabetic activity: a-amylase inhibitory
assay
In this test, P. lentiscus ethanolic extract tested above for its
in vivo antidiabetic activity was investigated for its potential to
inhibit porcine pancreatic a-amylase activity. Three different
concentrations (20 mg/mL, 60 mg/mL, and 100 mg/mL) of PL and
PF ethanolic extracts were used, compared with acarbose
(Figure 10). The latter compound (100 mg/mL) showed
79.34 ± 15.19% inhibitory effects on the a-amylase activity
with an IC50 value of 64.56 mg/mL, significantly surpassing PL
(55.86 ± 7.75%; IC50: 87.5 mg/mL) and PF (34.50 ± 7.74%; IC50:
144.29 mg/mL) extracts at the same concentration. However, PL
extract showed higher efficiency in inhibiting alpha-amylase
than its PF counterpart, which is in agreement with the
in vivo antidiabetic effect.
A dose-dependent increase in percentage inhibitory activ-
ity implicates that the plant contains a substantial amount of
compounds that have the ability to curb diabetes by inhibiting
the conversion of starch to glucose. The present study has
proved, in consolidation with previous reports [54], that P.
lentiscus contains essential herbal bioactive compounds such
as flavanone glycosides and luteolin, with inhibiting enzyme
activities [61]. In addition, a clear link between polyphenols
and antidiabetic activity of herbal extracts has been shown
[62]. This study is the first to report a potential mode of action
of P. lentiscus similar to that of other plant extracts, andatment in mice with ethanolic extracts of Pistacia lentiscus
core of liverb Sinusoidal
dilatationFatty
degeneration
Degenerated
hepatocyte
0 0 0
4 2 3
0 0 1
0 0 1
0 0 0
b.w. paracetamol-treated group; GIII, 125 mg/kg b.w. P. lentiscus leaf
nolic extract-treated group; and GV, 63/63mg/kg b.w. P. lentiscus leaf/
no visible cell damage; Score 1¼ focal hepatocyte damage on <30% of
; Score 3 ¼ extensive, but focal, hepatocyte lesions >50%; and Score
Figure 8 e Effect of PL and PF crude extracts on liver pathologic analysis after paracetamol treatment in mice. Histological
changes in the liversofparacetamol-treated rats that receivedorallyPL (125mg/kgb.w.), PF (125mg/kgb.w.), oramixture (PL/PF;
63þ 63mg/kg b.w.) plant crude extracts are shown. Liverswere stainedwith hematoxylineeosinmethod. The animal groups
are as follows: GI, normal control group (normal central vein and architecture); GII, paracetamol group (completely necrosed);
GIII, PL-treated group (a very light necrosis); (GIV, PF-treated group [showing central vein containing blood (CV) and necrosis
around the central vein] (200£); and GV, PL/PF-treated group (light necrosis, which occupies a tiny surface of the organ, but the
rest of the organ is intact from both) (250£). b.w.¼ body weight; CV¼ central vein; FN¼ focal necrosis; PF¼ P. lentiscus fruits
crudeextract; PL¼P. lentiscus leavescrudeextract; PL/PF¼P. lentiscus leaves/fruits crudeextracts;S¼dilatedhepaticsinusoids.
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least in part, to the inhibition of a-amylase.4. Conclusion
It can be concluded that P. lentiscus extracts has a moderate
hepatoprotective effect on paracetamol-induced acute hepa-
titis, as evidenced by a decrease in tissue necrosis and by
reduced transaminase and MDA serum levels. Alternatively,
the hypoglycemic activity along with the protective effectagainst STZ challenge provides the scientific rationale for the
use of P. lentiscus in herbal antidiabetic therapy. The use of this
plant extract will be greatly beneficial to reduce the rate of
digestion and absorption of carbohydrates, thereby contrib-
uting to effective management of diabetes by decreasing
postprandial hyperglycemia. Future studies will provide more
insight into the molecular mechanisms by which this plant
and its active compounds regulate glucose homeostasis.
Finally, the observed activities can be due to the presence of a
large spectrum of phytoconstituents revealed by polyphenol
quantification, FTIR, and HPLC-DAD analyses.
Figure 9 e Glucose levels in treated groups. All values are
expressed as mean ± SEM, n ¼ 6. One-way ANOVA
followed by Dunnett multiple comparison test was used for
statistical significance. The animal groups are as follows:
GI, diabetic control; GII, glibenclamide-treated group; GIII,
50 mg/kg b.w. PL-treated group; GIV, 125 mg/kg b.w. PL-
treated group; GV, 50 mg/kg b.w. PF-treated group; and
GVI, 125 mg/kg b.w. PF-treated group. * Values deviate
significantly (p < 0.05) from diabetic control. *** Values
deviate very significantly (p < 0.001) when compared with
diabetic control values. ANOVA ¼ analysis of variance;
b.w. ¼ body weight; PF ¼ Pistacia lentiscus fruits; PL ¼ P.
lentiscus leaves; SEM ¼ standard error of the mean.
Figure 10 e Comparison of a-amylase inhibitory effect of
Pistacia lentiscus ethanolic leaf and fruit extracts at
different concentrations. All values are expressed as
mean ± SD, n ¼ 3. One-way ANOVA followed by Dunnett
multiple comparison test was used for statistical
significance, when compared with acarbose. * p < 0.05. **
p < 0.01. *** p < 0.001. ANOVA ¼ analysis of variance;
SD ¼ standard deviation.
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